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Editorial
Understanding the Role of Additives in Tobacco Products
Tobacco products are highly engineered, from the tobacco itself 
through to the paper and filter (in the case of manufactured cig-
arettes). While nicotine is the primary addictive constituent of 
tobacco, the dose and speed of nicotine delivery can be influenced, 
directly and indirectly, in a variety of ways. This can include the 
use of additives; for example, additives that increase the availability 
of free nicotine may increase the dose of nicotine delivered, while 
those that facilitate deeper inhalation in smoked tobacco products 
may enhance addictiveness indirectly. Understanding the contribu-
tion of additives (as well as other naturally occurring constituents of 
tobacco) to the initiation and maintenance of tobacco use is vital to 
informing tobacco regulatory efforts.
To this end, van de Nobelen and colleagues1 describe guidelines 
and recommendations for developing a regulatory strategy for assess-
ing the role and impact of tobacco additives. They acknowledge 
many of the challenges inherent in this task and, in particular, in dis-
secting the role of individual additives when these are delivered in the 
complex matrix of constituents that make up both unburned tobacco 
and tobacco smoke. The 2010 report by the Scientific Committee on 
Emerging and Newly Identified Health Risks (SCENIHR),2 which 
provides scientific advice to the European Commission, empha-
sized the need to distinguish between additives that may be addic-
tive themselves, those that may enhance the addictiveness of nicotine 
and those that may increase the attractiveness of tobacco products. 
Understanding the role of additives requires experimental studies in 
both animals and humans, and these can include a range of outcome 
measures, ranging from self-reported psychological measures (in par-
ticular when assessing attractiveness or appeal) to biomarkers such as 
metabolites and patterns of brain activation.
The 2010 SCENIHR report describes criteria for assessing 
addictiveness in both human and animal studies. In human studies, 
clinical criteria for dependence, as well as laboratory measures of 
self-administration and choice preference, exist. These confirm the 
addictiveness of tobacco, but have only limited ability to assess the 
addictiveness of individual additives, in part because of the consider-
able variability in experimental paradigms used, in the absence of a 
widely agreed universal standard. In animal studies the reinforcing 
potential of a drug (eg, nicotine) can be used as a criterion, but these 
studies are limited by the general reliance on self-administration of 
nicotine as a model, which is some way removed from the delivery 
of nicotine in the vehicle of tobacco smoke. It is also possible to 
assess the effects of additives on the speed and dose of nicotine deliv-
ered, for example, by the levels of nicotine (or cotinine, the primary 
metabolite of nicotine) in blood and on the activation of relevant 
neural pathways, such as the mesolimbic dopamine system1.
Therefore, while there are clearly challenges to assessing the 
impact of additives on the addictiveness and attractiveness of 
tobacco products, these are not entirely insurmountable. Important 
gaps in our knowledge remain, such as the impact of sugar levels in 
tobacco, and the role of noncombustible tobacco products, as well 
as in e-cigarettes.3 Even the impact of widely studied additives, such 
as menthol4 and ammonia,5 remains poorly understood. Developing 
this understand will be critical if research is to guide the develop-
ment of evidence-based policy to regulate and restrict additives in 
these products and reduce their addictiveness and attractiveness.
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